https://www.selleckchem.com/products/ipi-549.html
The secondary outcomes include AF burden at 3 months after CA, recurrence of AF, quality of life, etc. The adverse events will also be recorded. This pilot study will contribute to evaluating the feasibility, preliminary efficacy, and safety of acupuncture in reducing AF burden for persistent AF after CA.The results will be used for the sample size calculation of a subsequent large-scale trial. Chinese Clinical Trial Registry ChiCTR2000030576 . Registered on 7 March 2020. Chinese Clinical Trial Registry ChiCTR2000030576 . Registered on
Aimer
Commentaire
Partagez
